Cargando…
Normalisation of glucose metabolism by exendin‐4 in the chronic phase after stroke promotes functional recovery in male diabetic mice
BACKGROUND AND PURPOSE: Glucagon‐like peptide‐1 (GLP‐1) receptor activation decreases stroke risk in people with Type 2 diabetes (T2D), while animal studies have shown the efficacy of this strategy to counteract stroke‐induced acute brain damage. However, whether GLP‐1 receptor activation also impro...
Autores principales: | Augestad, Ingrid Lovise, Dekens, Doortje, Karampatsi, Dimitra, Elabi, Osama, Zabala, Alexander, Pintana, Hiranya, Larsson, Martin, Nyström, Thomas, Paul, Gesine, Darsalia, Vladimer, Patrone, Cesare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820185/ https://www.ncbi.nlm.nih.gov/pubmed/33973246 http://dx.doi.org/10.1111/bph.15524 |
Ejemplares similares
-
Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
por: Trapp, Stefan, et al.
Publicado: (2021) -
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
por: Helmstädter, Johanna, et al.
Publicado: (2021) -
Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands
por: Tanday, Neil, et al.
Publicado: (2021) -
Glucagon‐like peptide‐1 (GLP‐1) signalling in the brain: From neural circuits and metabolism to therapeutics
por: Kabahizi, Anita, et al.
Publicado: (2021) -
The role of nucleus of the solitary tract glucagon‐like peptide‐1 and prolactin‐releasing peptide neurons in stress: anatomy, physiology and cellular interactions
por: Holt, Marie K., et al.
Publicado: (2021)